...for ophthalmologists’ affinity in Eylea HD, Vabysmo matchup
After seven months on the market, Regeneron’s Eylea HD is already making strides with ophthalmologists. According to Spherix Global Insights’ research, 81% of ophthalmologists who … Sign up to ...